GLP-1 weight loss drugs may be misused by patients with eating disorders: Study
New research indicates that GLP-1 receptor agonists, including Ozempic, are being misused by individuals with eating disorders.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
A study indicated that GLP-1 receptor agonists may be misused by patients with eating disorders to sustain their conditions. Reports noted that such misuse occurred at an alarming rate.
The story quieted without a definitive conclusion in the coverage.
Epilogue added 10d ago, after coverage quieted.
The brief
A study published in JAMA suggests that GLP-1 receptor agonists are commonly misused by people with eating disorders. According to reports from NewsNation and ABC News, these weight-loss injections may be used to sustain eating disorders.
Coverage from Medical Republic and Gizmodo emphasizes the misuse of these drugs, specifically mentioning Ozempic. WFMZ.com describes the rate of misuse among this patient population as alarming, while Psychology Today notes that for some patients, the feeling of being in control is a symptom rather than a positive outcome.
Future focus remains on the intersection of GLP-1 drug use and the maintenance of eating disorders, as highlighted by MedPage Today and Medical Dialogues.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 19d ago.
Quick answers
Which medical journal published the findings?
The study was published in JAMA, according to Medical Dialogues.
What specific drug is mentioned in the coverage?
Gizmodo specifically mentions the misuse of Ozempic.
How is the rate of misuse described?
WFMZ.com reports that eating disorder patients misuse these weight-loss injections at an alarming rate.
Coverage (9)
- For some patients, feeling in control is a symptom, not the outcome. Psychology Today · 22d ago
- GLP-1 Receptor Agonist Use and Misuse Common Among People With Eating Disorders: JAMA Medical Dialogues · 22d ago
- GLP-1s may be misused by patients with eating disorders: Study NewsNation · 22d ago
- For some patients, feeling in control is a symptom, not the outcome. Psychology Today · 22d ago
- Are People With Eating Disorders Misusing GLP-1 Drugs? MedPage Today · 22d ago
- Health Beat: Study reveals eating disorder patients misuse weight-loss injections at alarming rate WFMZ.com · 22d ago
- GLP-1 RAs being used to sustain eating disorders Medical Republic · 22d ago
- People With Eating Disorders Are Misusing Ozempic Gizmodo · 22d ago
- GLP-1 weight loss drugs may be misused by patients with eating disorders: Study ABC News - Breaking News, Latest News and Videos · 22d ago
Topics
Related trends
She Used Weight-Loss Drugs From a Telehealth Company, Then a GLP-1 Overdose Sent Her to the ER
Rising concerns over GLP-1 weight-loss drug overdoses are linked to dosing errors and the use of telehealth services.
Weight-loss drugs didn't improve mental health or job prospects
Recent analyses suggest weight-loss drugs may not deliver broader improvements to mental health, job prospects, or overall quality of life.
Can Ozempic prevent cancer? A doctor explains why the headlines are easy to misread
Medical discussions are intensifying over whether GLP-1 medications like Ozempic can prevent cancer or influence oncology recovery.
Low-protein ‘longevity diet’ helped mice live healthier, leaner lives: Study
A new study suggests a low-protein 'longevity diet' may help reduce body fat and increase natural GLP-1 levels.
Why your health plan doesn’t cover GLP-1s, according to a top insurance exec
Insured patients are facing challenges accessing GLP-1 weight-loss drugs as coverage policies and payment models shift.
New weight loss pill that’s beating oral Ozempic
A new oral GLP-1 weight-loss pill is showing results that outperform oral Ozempic in major clinical trials.